Allan Marchington

Allan Marchington is the Managing Director and Head of Life Sciences at Intermediate Capital Group (ICG), a position he has held since January 2021. In this role, he is responsible for overseeing the strategy and operations of ICG's Life Sciences Fund, which focuses on investments in the life sciences sector, including biotechnology and pharmaceuticals.13

Professional Background

Before joining ICG, Marchington was the Founder and Managing Partner of Bridge Valley Ventures, where he led investments in life sciences companies. He also co-founded Apposite Capital, further establishing his expertise in the field.15 His experience encompasses both investment and operational roles, emphasizing the importance of collaboration between management teams and investors to drive successful outcomes in drug development.1

Philosophy and Approach

Marchington advocates for a patient-centered investment philosophy, aiming to develop treatments that significantly impact patients' lives. His team at ICG combines extensive industry knowledge with a commitment to fostering long-term relationships with portfolio companies, ensuring they provide not just capital but also strategic support.13

Education and Skills

Allan Marchington's background is rooted in both science and business, allowing him to effectively navigate the complexities of life sciences investments. His approach involves rigorous due diligence and a focus on teams that have successfully brought drugs through clinical trials.14

For more insights into his professional journey, you can view his LinkedIn profile under the username allanmarchington.2